Sensus Healthcare (SRTS) Capital Expenditures (2017 - 2026)
Sensus Healthcare's (SRTS) quarterly Capital Expenditures came in at -$74000.0 in Q1 2026, down 1157.14% year-on-year from $7000.0 in Q1 2025, and up 58.43% quarter-over-quarter from -$178000.0 in Q4 2025.
Sensus Healthcare (SRTS) Capital Expenditures (2017 - 2026) Analysis & Trends
Sensus Healthcare's Capital Expenditures history runs 10 years deep, the most recent figure standing at -$74000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures fell 1157.14% year-over-year to -$74000.0 in Q1 2026; TTM through Mar 2026 was -$93000.0, a 286.0% decrease from a year earlier, with the FY2025 full-year figure at -$12000.0, down 104.35% from the prior year.
- Capital Expenditures rose to -$74000.0 in Q1 2026 per SRTS's latest filing, from -$178000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $490000.0 in Q4 2024 and bottomed at -$382000.0 in Q2 2024.
- The 5-year median for Capital Expenditures is $44000.0 (2022), against an average of $54058.8.
- Across the five-year window, Capital Expenditures soared 23400.0% in 2024 and slumped 1157.14% in 2026, its largest moves.
- Year by year, Capital Expenditures stood at $268000.0 in 2022, then sank by 69.03% to $83000.0 in 2023, then jumped by 490.36% to $490000.0 in 2024, then sank by 136.33% to -$178000.0 in 2025, then jumped by 58.43% to -$74000.0 in 2026.
- Per Business Quant, the three latest SRTS Capital Expenditures figures stand at -$74000.0 (Q1 2026), -$178000.0 (Q4 2025), and $132000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | -74,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74,000.00 |
| Mar 31, 2026 | -74,000.00 |
| Dec 31, 2025 | -178,000.00 |
| Dec 31, 2025 | -178,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 490,000.00 |
| Dec 31, 2024 | 490,000.00 |
| Sep 30, 2024 | -65,000.00 |
| Sep 30, 2024 | -65,000.00 |
| Jun 30, 2024 | -382,000.00 |
| Jun 30, 2024 | -382,000.00 |
| Mar 31, 2024 | 233,000.00 |
| Mar 31, 2024 | 233,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Dec 31, 2023 | 83,000.00 |